208665 Calmidazolium Chloride - CAS 57265-65-3 - Calbiochem

208665
가격을 검색할 수 없습니다
Minimum Quantity needs to be mulitiple of
가격 문의 추가 정보
()이 할인됨
 
가격 문의
재고 없음재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service
      가격 및 재고 조회

      개요

      Replacement Information

      주요 사양표

      Empirical FormulaCAS #
      C₃₁H₂₃Cl₇N₂O 57265-65-3

      가격 및 재고여부

      카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
      208665-10MGCN
      재고 정보 검색...
      재고 없음재고 없음
      예상 출고 가능일 
      단종품
      제한된 수량 가능
      재고여부 확인
        Remaining: will advise
          Remaining: will advise
          추천사항
          고객 서비스로 문의
          Contact Customer Service

          Plastic ampoule 10 mg
          가격 검색...
          가격을 검색할 수 없습니다
          Minimum Quantity needs to be mulitiple of
          가격 문의 추가 정보
          ()이 할인됨
           
          가격 문의
          Description
          OverviewA cell-permeable calmodulin antagonist. At least 150 times more potent than Trifluoperazine (Cat. No. 642150) as an inhibitor of brain calmodulin-dependent phosphodiesterase (IC50 = 10 nM). An inhibitor of voltage-gated Ca2+ channels. Stimulates the release of nitric oxide in neuroblastoma cells. Also acts as a strong non-competitive inhibitor of skeletal muscle sarcoplasmic reticulum Ca2+-ATPase (Ki = 60 nM). Known to prolong cardiac refractoriness in vivo.
          Note: easily adheres to glass in aqueous solution.
          Catalogue Number208665
          Brand Family Calbiochem®
          SynonymsCompound R 24571
          References
          ReferencesHu, J., and El-Fakahany, E.E. 1993. NeuroReport. 4, 198.
          Nakazawa, K., et al. 1993. Br. J. Pharmacol. 109, 137.
          Yuasa, T., and Muto, S. 1992. Arch. Biochem. Biophys. 296, 175.
          Ichikawa, M., et al. 1991. J. Membrane Biol. 120, 211.
          Silver, P.J., et al. 1989. Cardiovasc. Drug Ther. 3, 675.
          Anderson, K.W., et al. 1984. J. Biol. Chem. 259, 11487.
          Gietzen, L., et al. 1982. Biochem. J. 207, 541.
          Van Belle, H. 1981. Cell Calcium 2, 483.
          Levin, R.N., and Weiss, B. 1979. J. Pharmacol. Exp. Therap. 208, 454.
          Product Information
          CAS number57265-65-3
          ATP CompetitiveN
          FormWhite solid
          Hill FormulaC₃₁H₂₃Cl₇N₂O
          Chemical formulaC₃₁H₂₃Cl₇N₂O
          ReversibleN
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Biological Information
          Primary Targetbrain calmodulin-dependent phosphodiesterase
          Primary Target IC<sub>50</sub>10 nM against brain calmodulin-dependent phosphodiesterase
          Purity≥95% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage -20°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C) for long term storage or refrigerate (4°C) for short-term storage. DMSO stock solutions are stable for up to 2 months -20°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Calmidazolium Chloride - CAS 57265-65-3 - Calbiochem MSDS

          타이틀

          물질안전보건자료(MSDS) 

          Calmidazolium Chloride - CAS 57265-65-3 - Calbiochem Certificates of Analysis

          TitleLot Number
          208665

          References

          참고문헌 보기
          Hu, J., and El-Fakahany, E.E. 1993. NeuroReport. 4, 198.
          Nakazawa, K., et al. 1993. Br. J. Pharmacol. 109, 137.
          Yuasa, T., and Muto, S. 1992. Arch. Biochem. Biophys. 296, 175.
          Ichikawa, M., et al. 1991. J. Membrane Biol. 120, 211.
          Silver, P.J., et al. 1989. Cardiovasc. Drug Ther. 3, 675.
          Anderson, K.W., et al. 1984. J. Biol. Chem. 259, 11487.
          Gietzen, L., et al. 1982. Biochem. J. 207, 541.
          Van Belle, H. 1981. Cell Calcium 2, 483.
          Levin, R.N., and Weiss, B. 1979. J. Pharmacol. Exp. Therap. 208, 454.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision18-June-2009 JSW
          SynonymsCompound R 24571
          DescriptionA cell-permeable calmodulin antagonist. An analog of sepazonium that is at least 150 times more potent than Trifluoperazine (Cat. No. 642150) as an inhibitor of brain Ca2+-calmodulin-dependent phosphodiesterase (IC50 = 10 nM). Inhibits voltage-gated Ca2+ channels and stimulates the release of nitric oxide in neuroblastoma cells. Also, acts as a strong inhibitor of calcium-dependent Ca2+-ATPase in erythrocytes. Known to prolong cardiac refractory period in vivo.
          FormWhite solid
          CAS number57265-65-3
          Chemical formulaC₃₁H₂₃Cl₇N₂O
          Structure formulaStructure formula
          Purity≥95% by HPLC
          SolubilityDMSO (10 mg/ml) or EtOH (10 mg/ml). Note: readily adheres to glass in aqueous solution.
          Storage -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C) for long term storage or refrigerate (4°C) for short-term storage. DMSO stock solutions are stable for up to 2 months -20°C.
          Toxicity Standard Handling
          ReferencesHu, J., and El-Fakahany, E.E. 1993. NeuroReport. 4, 198.
          Nakazawa, K., et al. 1993. Br. J. Pharmacol. 109, 137.
          Yuasa, T., and Muto, S. 1992. Arch. Biochem. Biophys. 296, 175.
          Ichikawa, M., et al. 1991. J. Membrane Biol. 120, 211.
          Silver, P.J., et al. 1989. Cardiovasc. Drug Ther. 3, 675.
          Anderson, K.W., et al. 1984. J. Biol. Chem. 259, 11487.
          Gietzen, L., et al. 1982. Biochem. J. 207, 541.
          Van Belle, H. 1981. Cell Calcium 2, 483.
          Levin, R.N., and Weiss, B. 1979. J. Pharmacol. Exp. Therap. 208, 454.